Long-Acting Local Anesthetics and Perioperative Pain Management

Dental Clinics of North America

Volumn 54, Issue 4, 2010, Pages 611-620

  Gordon, Sharon M ^a   Mischenko, Anastasia V ^a   Dionne, Raymond A ^b  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b NATIONAL INSTITUTE OF NURSING RESEARCH   (United States)

Author keywords

Bupivacaine; Inflammation; Lidocaine; Local anesthetics; Postoperative pain

Indexed keywords

BUPIVACAINE; LOCAL ANESTHETIC AGENT;

CHEMICALLY INDUCED DISORDER; DENTAL ANESTHESIA; DRUG EFFECT; HUMAN; INFLAMMATION; METHODOLOGY; NOCICEPTION; NOCICEPTIVE RECEPTOR; PERIOPERATIVE PERIOD; POSTOPERATIVE PAIN; REVIEW; TIME;

ANESTHESIA, DENTAL; ANESTHETICS, LOCAL; BUPIVACAINE; HUMANS; INFLAMMATION; NOCICEPTORS; PAIN PERCEPTION; PAIN, POSTOPERATIVE; PERIOPERATIVE CARE; TIME FACTORS;

EID: 77956442038     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cden.2010.06.002     Document Type: Review

References (56)

1. Rozkowski M.T., Swift J.Q., Hargreaves K.M., et al. Effect of NSAID administration on tissue levels of immunoreactive prostaglandin E2, leukotriene B4, and (S)-fluribiprofen following extraction of impacted third molars. Pain 1997, 73:339-345.
2. Woolf C.J., Chong M.S. Pre-emptive analgesia-treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg 1993, 77(2):362-379.
3. Hietbrink F., Koenderman L., Rijkers G., et al. Trauma: the role of the innate immune system. World J Emerg Surg 2006, 1:15.
4. Pape H.C., Grimme K., Van Griensven M., et al. Impact of intramedullary instrumentation versus damage control for femoral fractures on immunoinflammatory parameters: prospective randomized analysis by the EPOFF Study Group. J Trauma 2003, 55(1):7-13.
5. Gordon S.M., Chuang B.P., Wang X.M., et al. The differential effects of bupivacaine and lidocaine on prostaglandin E2 release, cyclooxygenase gene expression and pain in a clinical pain model. Anesth Analg 2008, 106(1):321-327.
6. Dionne R.A., Cooper S.A. Evaluation of preoperative ibuprofen on postoperative pain after impaction surgery. Oral Surg Oral Med Oral Pathol 1978, 45:851-856.
7. Kvist T., Reit C. Postoperative discomfort associated with surgical and nonsurgical endodontic retreatment. Endod Dent Traumatol 2000, 16(2):71-74.
8. Seymour R.A., Meechan J.G., Blair G.S., et al. Postoperative pain after apicoectomy. A clinical investigation. Int Endod J 1986, 19(5):242-247.
9. Dionne R.A., Wirdzek P.R., Fox P.C., et al. Suppression of postoperative pain by the combination of a nonsteroidal anti-inflammatory drug, flurbiprofen, and a long-acting local anesthetic, etidocaine. J Am Dent Assoc 1984, 108:598-601.
10. Watkins L.R., Maier S.F., Gohler L.E. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 1995, 63(3):289-302.
11. Tsesis I., Fuss Z., Lin S., et al. Analysis of postoperative symptoms following surgical endodontic treatment. Quintessence Int 2003, 34(10):756-760.
12. Walton R.E., Torabinejad M. Managing local anesthesia problems in the endodontic patient. J Am Dent Assoc 1992, 123(5):97-102.
13. Moore P.A., Dunsky J.L. Bupivacaine anesthesia-a clinical trial for endodontic therapy. Oral Surg Oral Med Oral Pathol 1983, 55(2):176-179.
14. Gordon S.M., Brahim J.S., Dubner R., et al. Attenuation of pain in a randomized trial by suppression of peripheral nociceptive activity in the immediate postoperative period. Anesth Analg 2002, 95(5):1351-1357.
15. Gordon S.M., Dionne R.A., Brahim J., et al. Blockade of peripheral neuronal barrage reduces postoperative pain. Pain 1997, 70:209-215.
16. Kaurich M.J., Otomo-Corgel J., Nagy R.J., et al. Comparison of postoperative bupivacaine with lidocaine on pain and analgesic use following periodontal surgery. J West Soc Periodontol Periodontal Abstr 1997, 45(1):5-8.
17. Truollos E.S., Hargreaves K.M., Butler D.P., et al. Comparison of nonsteroidal anti-inflammatory drugs, ibuprofen and flurbiprofen, to methylprednisolone and placebo for acute pain, swelling, and trismus. J Oral Maxillofac Surg 1990, 48:945-952.
18. Gordon S.M., DeFina V., Dionne R.A., et al. Quality of life in patients experiencing acute and chronic pain. Presented at the Annual Meeting of the American Pain Society. Washington, DC May, 2006.
19. Nespeca J.A. Clinical trials with bupivacaine in oral surgery. Oral Surg Oral Med Oral Pathol 1976, 42(3):301-307.
20. Moore P.A. Bupivacaine: a long-lasting local anesthetic for dentistry. Oral Surg Oral Med Oral Pathol 1984, 58(4):369-374.
21. El-Sharrawy E., Yagiela J.A. Anesthetic efficacy of different ropivacaine concentrations for inferior alveolar nerve block. Anesth Prog 2006, 53:3-7.
22. Kennedy M., Reader A., Beck M. Anesthetic efficacy of ropivacaine in maxillary anterior infiltration. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001, 91:406-412.
23. Meechan J.G. A comparison of ropivacaine and lidocaine with epinephrine for intraligamentary anesthesia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002, 93:469-473.
24. Axelsson S., Isacsson G. The efficacy of ropivacaine as a dental local anaesthetic. Swed Dent J 2004, 28:85-91.
25. Nahourali H.S., ZorkosWisnieoski R. Dental therapeutic practice patterns in the US I: anesthesia and sedation. Gen Dent 2006, 54(2):92-98.
26. Covino B.G., Giddon D.B. Pharmacology of local anesthetic agents. J Dent Res 1981, 60(8):1454-1459.
27. Curtis J.W., McLain J.B., Hutchinson R.A., et al. The incidence and severity of complications and pain following periodontal surgery. J Periodontol 1986, 57(10):637-642.
28. Matinsson T., Haegerstrand A., Dalsgard C.J., et al. Ropivacaine and lidocaine inhibit proliferation of nontransformed cultured adult human fibroblasts, endothelial cells, and keratinocytes. Agents Actions 1993, 40:78-85.
29. Hirata M., Sakaguchi M., Mochida C., et al. Lidocaine inhibits tyrosine kinase activity of the epidermal growth factor receptor and suppresses proliferation of corneal epithelial cells. Anesthesiology 2004, 100(5):1206-1210.
30. Eriksson A.S., Sinclair R. Leukocyte hydrogen peroxide production in a surgical wound in mice. The effects of an amide local aneasthetic. Inflammation 1996, 20(5):569-579.
31. Eroglu E., Eroglu F., Agalar F., et al. The effect of lidocaine/prilocaine cream on an experimental wound healing model. Eur J Emerg Med 2001, 8(3):199-201.
32. Drucker M., Cardenas E., Arizti P., et al. Experimental studies on the effect of lidocaine on wound healing. World J Surg 1998, 22(4):394-397.
33. Lahav M., Levite M., Bassani L., et al. Lidocaine inhibits secretion of IL-8 and IL-1beta and stimulates secretion of IL-1 receptor antagonist by epithelial cells. Clin Exp Immunol 2002, 127:226-233.
34. Scherb M.B., Seung-Hwan H., Coumeya J.P., et al. Effect of bupivacaine on cultured tenocytes. Orthopedics 2009, 32:26-30.
35. Chu C.R., Izzo N.J., Papas N.E., et al. In vitro exposure of 0.5% bupivacaine is cytotoxic to bovine articular chondrocytes. Arthroscopy 2006, 22:693-699.
36. Pere P., Watanabe H., Pitkanen M., et al. Local myotoxicity of bupivacaine in rabbits after continuous supraclavicular brachial plexus block. Reg Anesth 1993, 18:304-307.
37. Takahashi S. Local anesthetic bupivacaine alters function of sarcolasmic reticulum and sarcolemnal vesicles from rabbit masseter muscle. Pharmacol Toxicol 1994, 75:119-128.
38. Piper S.L., Kim H.T. Comparison of ropivacaine and bupivacaine toxicity in human articular chondrocytes. J Bone Joint Surg Am 2008, 90:986-991.
39. Guttu R.L., Page D.G., Laskin D.M., et al. Delayed healing of muscle after injection of bupivicaine and steroid. Ann Dent 1990, 49(1):5-8.
40. Orimo S., Hiyamuta E., Arahata K., et al. Analysis of inflammatory cells and complement C3 in bupivacaine-induced myonecrosis. Muscle Nerve 1991, 14(6):515-520.
41. Park C.Y., Park S.E., Oh S.Y., et al. Acute effect of bupivacaine and ricin mAb 35 on extraocular muscle in the rabbit. Curr Eye Res 2004, 29:293-301.
42. Yamashita A, Matsumoto M, Matsumoto S et al. A comparison of the neurotoxic effects on the spinal cord of tetracaine, lidocaine, bupivacaine, and ropivacaine administered intrathecally in rabbits. Anesth Analg 97:512-9.
43. Gold M.S., Reichling D.B., Hampl K.F., et al. Lidocaine toxicity in primary afferent neurons from the rat. J Pharmacol Exp Ther 1998, 285:413-421.
44. Gristwood R.W. Cardiac and CNS toxicity of levobupivacaine; strengths of evidence for advantage over bupivacaine. Drug Saf 2002, 25:153-163.
45. Maganella C., Bruno V., Matrisciano F., et al. Comparative effects of levobupivacaine and racemic bupivacaine on excitotoxic neuronal death in culture and N-methyl-D-aspartate-induced seizures in mice. Eur J Pharmacol 2005, 518:111-115.
46. Radwan I., Aito S., Goto F., et al. The neurotoxicity of local anesthetics on growing neurons: a comparative study of lidocaine, bupivacaine, mepivacaine, and ropivacaine. Anesth Analg 2002, 94:319-324.
47. Johnson M.E., Saenz J.A., DaSilva A.D., et al. Effect of local anesthetic on neuronal cytoplasmic calcium and plasma membrane lysis (necrosis) in a cell culture model. Anesthesiology 2002, 97:1466-1476.
48. Sakura S., Bollen A.W., Ciriales R., et al. Local anesthetic neurotoxicity does not result from blockade of voltage-gated sodium channels. Anesth Analg 1995, 81:338-346.
49. Mischenko A., Letwin N., Hicks L., et al. Comparison of bupivacaine vs lidocaine on inflammatory regulation July, 2010, International Association of Dental Research. Barcelona, Spain.
50. Buvanendran A., Kroin J.S., Berger R.A., et al. Upregulation of prostaglandin E2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans. Anesthesiology 2006, 104(3):403-410.
51. Kroin J.S., Buvanendran A., Watts D.E., et al. Upregulation of cerebrospinal fluid and peripheral prostaglandin E2 in a rat postoperative pain model. Anesth Analg 2006, 103(2):334-343.
52. Mischenko A., Wills K., Letwin N., et al. Bupivacaine increases PGE2 expression in vivo. Presented at the Annual Meeting of the American Association of Endodontists. Orlando, FL April, 2009.
53. Chiang N., Schwab J.M., Fredman G., et al. Anesthetics impact the resolution of inflammation. PLoS One 2008, 3(4):e1879.
54. Gomoll A.H., Kang R.W., Wiliams J.M., et al. Chondrolysis after continuous intra-articular bupivacaine infusion: an experimental model investigating chondrotoxicity in the rabbit shoulder. Arthroscopy 2006, 22(8):813-819.
55. Bouloux G.F., Punnia-Moorthy A. Bupivacaine versus lidocaine for third molar surgery: a double-blind, randomized, crossover study. J Oral Maxillofac Surg 1999, 57(5):510-514. [discussion: 515].
56. Feinstein D.L., Murphy P., Sharp A., et al. Local anesthetics potentiate nitric oxide synthase type 2 expression in rat glial cells. J Neurosurg Anesthesiol 2001, 13:99-105.